Article

Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates

2021-05-24

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Vaccine efficacy against the B.1.351 variant following mRNA-1273 vaccination in humans has not been determined. Nonhuman primates (NHP) are a useful model for demonstrating whether mRNA-1273 mediates protection against B.1.351. <h4>Methods</h4> Nonhuman primates received 30 or 100 µg of mRNA-1273 as a prime-boost vaccine at 0 and 4 weeks, a single immunization of 30 µg at w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c7b24f45-1d0c-536a-a118-8e90d06062e3
DOI: 10.1101/2021.05.21.445189

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesDOI 10.1101/2021.05.21.445189Read

Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman PrimatesSemantic proximity Read

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman PrimatesSemantic proximity Read

mRNA-1273 vaccination protects against SARS-CoV-2 elicited lung inflammation in non-human primatesSemantic proximity Read

Serum Neutralizing Activity of mRNA-1273 Against the SARS-CoV-2 B.1.1.529 (Omicron) Variant: A Preliminary ReportSemantic proximity Read

mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeSemantic proximity Read

mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2Semantic proximity Read

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 VariantsSemantic proximity Read

mRNA-1273 and Ad26.COV2.S Vaccines Protect Against the B.1.621 Variant of SARS-CoV-2Semantic proximity Read

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsSemantic proximity Read

Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.Semantic proximity Read

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine — An Interim AnalysisSemantic proximity Read

Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesSemantic proximity Read